Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 41,699 | -107,458 | -124,377 | -76,180 | -23,215 |
| Depreciation Amortization | 15,362 | 12,937 | 8,454 | 6,077 | 4,421 |
| Accounts receivable | -27,573 | -11,512 | -1,042 | 10,860 | -13,545 |
| Other Working Capital | -58,743 | 84,326 | 3,607 | 12,017 | -15,254 |
| Other Operating Activity | 12,346 | 15,574 | 2,835 | -10,094 | 19,683 |
| Operating Cash Flow | $-16,909 | $-6,133 | $-110,523 | $-57,320 | $-27,910 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,394 | -19,957 | -24,146 | -67,162 | -51,181 |
| PPE Investments | -6,174 | -29,656 | -34,370 | -8,223 | -6,495 |
| Investing Cash Flow | $10,220 | $-49,613 | $-58,516 | $-75,385 | $-57,676 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,827 | 13,656 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 192,703 | N/A |
| Debt Repayment | N/A | -150 | -426 | -572 | -1,436 |
| Common Stock Issued | 1,502 | 94,678 | 2,149 | 158,522 | 94,365 |
| Common Stock Repurchased | -888 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -1,533 | -62 |
| Financing Cash Flow | $4,441 | $108,184 | $1,723 | $349,120 | $92,867 |
| Beginning Cash Position | 97,477 | 45,039 | 247,393 | 30,978 | 23,697 |
| End Cash Position | 95,229 | 97,477 | 80,077 | 247,393 | 30,978 |
| Net Cash Flow | $-2,248 | $52,438 | $-167,316 | $216,415 | $7,281 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,909 | -6,133 | -110,523 | -57,320 | -27,910 |
| Capital Expenditure | -6,174 | -29,656 | -34,370 | -8,223 | -6,495 |
| Free Cash Flow | -23,083 | -35,789 | -144,893 | -65,543 | -34,405 |